Showing 1 - 10 of 14,183
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and...
Persistent link: https://www.econbiz.de/10013473290
Drugs and medicines account for about half of the total medical out-of-pocket expenses of households. This share of drugs to total medical expenses is much higher for the poor than the rich. Thus, affordability of medicines is an important issue in poverty reduction. Recent efforts to improve...
Persistent link: https://www.econbiz.de/10009379586
Persistent link: https://www.econbiz.de/10011300733
There is widespread concern about the quality of care in nursing homes. Based on administrative data of a large health insurance fund, we investigate whether nursing home prices affect relevant quality of care indicators at the resident level. Our results indicate a significantly negative price...
Persistent link: https://www.econbiz.de/10010238834
Health authorities are constantly searching for new ways to stabilise health expenditures. To explore this issue, we compared the costs generated by different types of medical practice in French general medicine: i.e. conventional (CM-GP), homeopathic (Ho-GP), or mixed (Mx-GP). Data from a...
Persistent link: https://www.econbiz.de/10011471577
of a traditional fee-for-service insurance plan. -- Pharmaceuticals ; discrete choice model ; funding schemes …
Persistent link: https://www.econbiz.de/10003826591
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8% of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10013136585
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10013118139
Health economists have largely ignored complementary and alternative medicine (CAM) as an area of research, although both clinical experiences and several empirical studies suggest cost-effectiveness of CAM. The objective of this paper is to explore the cost-effectiveness of CAM compared to...
Persistent link: https://www.econbiz.de/10013123914
Persistent link: https://www.econbiz.de/10013169424